Aptagen, LLC
* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
Gelatinase (MMP-9) (ID# 7625)
Peptide
Matrix Metalloproteinase-9 (MMP-9)
Protein
N/A nM (reported value)
Incubated overnight at 4 ° C in binding buffer (50 mM TBS buffer (Tris-HCl/0.1 M NaCl, pH 7.5) containing 1% BSA).
N/A°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
Inhibits the migration of human endothelial and tumor cells.
NH2-CysThrThrHisTrpGlyPheThrLeuCys-COOH
10
1268.54
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Koivunen et al. "Tumor targeting with a selective gelatinase inhibitor." Nature Biotechnology, 17(1999): 768 - 774.
Have your aptamer oligo synthesized ORDER
We are always looking for ways to improve. Please tell us what you think.